Skip to main content
logo
Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China flag China · Delayed Price · Currency is CNY
27.96
+0.81 (2.98%)
At close: Apr 8, 2026

SHE:301263 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '26 Dec '24 Jan '24 Jan '23 Jan '22 Dec '20
Market Capitalization
11,8416,3486,9487,683--
Market Cap Growth
28.43%-8.63%-9.56%---
Enterprise Value
11,6846,0666,2716,685--
Last Close Price
27.9614.8815.8817.24--
PE Ratio
508.4458.6643.3744.00--
Forward PE
-25.8522.5228.32--
PS Ratio
17.568.819.139.81--
PB Ratio
6.553.503.804.14--
P/TBV Ratio
8.924.564.864.36--
P/FCF Ratio
-305.50-130.35--
P/OCF Ratio
306.1071.0774.2951.63--
EV/Sales Ratio
17.328.418.248.53--
EV/EBITDA Ratio
183.5237.3428.3729.48--
EV/EBIT Ratio
-55.1234.1434.32--
EV/FCF Ratio
-184.23291.91-113.43--
Debt / Equity Ratio
0.220.130.100.010.150.21
Debt / EBITDA Ratio
6.121.480.790.100.700.59
Debt / FCF Ratio
-11.68-0.391.453.90
Net Debt / Equity Ratio
-0.13-0.23-0.29-0.55-0.040.06
Net Debt / EBITDA Ratio
-3.73-2.59-2.40-4.52-0.180.15
Net Debt / FCF Ratio
3.65-20.284.99-17.38-0.381.02
Asset Turnover
0.290.320.360.530.740.94
Inventory Turnover
2.653.333.644.183.703.33
Quick Ratio
2.042.684.219.152.231.64
Current Ratio
2.383.054.699.812.662.20
Return on Equity (ROE)
0.77%5.32%8.33%13.62%18.47%28.25%
Return on Assets (ROA)
-0.04%3.03%5.38%8.17%8.98%15.85%
Return on Invested Capital (ROIC)
-0.11%7.51%13.78%21.71%17.07%26.73%
Return on Capital Employed (ROCE)
-0.10%5.70%9.30%10.30%17.30%31.00%
Earnings Yield
0.20%1.70%2.31%2.27%--
FCF Yield
-0.54%0.33%-1.53%0.77%--
Dividend Yield
0.74%1.34%1.89%2.26%--
Payout Ratio
405.57%124.86%104.11%49.14%3.56%42.37%
Buyback Yield / Dilution
-1.69%1.27%-6.23%-24.87%-6.49%-5.67%
Total Shareholder Return
-0.94%2.61%-4.34%-22.62%-6.49%-5.67%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.